{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:09:48Z","timestamp":1762520988233},"reference-count":31,"publisher":"Informa Healthcare","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1517\/14656566.2.6.1033","type":"journal-article","created":{"date-parts":[[2005,5,5]],"date-time":"2005-05-05T01:08:27Z","timestamp":1115255307000},"page":"1033-1042","source":"Crossref","is-referenced-by-count":33,"title":["Ziprasidone: a new atypical antipsychotic"],"prefix":"10.1517","volume":"2","author":[{"given":"Lesley M","family":"Arnold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L","family":"McElroy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul E","family":"Keck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,2,24]]},"reference":[{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3928\/0048-5713-19970501-04","volume":"27","author":"KECK PE Jr","year":"1997","journal-title":"Psychiatry Ann."},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/schbul\/13.1.133","volume":"13","author":"KANE JM","year":"1987","journal-title":"Schizophr: Bull"},{"key":"CIT0004","first-page":"327","volume":"157","author":"CARPENTER WT","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"CIT0006","first-page":"789","volume":"45","author":"KANE J","year":"1988","journal-title":"SINGER J etal.: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison versus chlorpromazine\/benztropine. Arch. Gen. Psychiatry"},{"key":"CIT0007","first-page":"529","volume":"114","author":"KECK PE Jr","year":"1994","journal-title":"Pharmacologic treatment of schizoaffective disorder. Psychopharmacology"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1017\/S1461145700002042","volume":"3","author":"GOLDSTEIN J","year":"2000","journal-title":"Neuropsychopharmacol"},{"key":"CIT0009","first-page":"101","volume":"275","author":"SEEGER TF","year":"1995","journal-title":"Ther"},{"key":"CIT0010","first-page":"154","volume":"15","author":"KO G","year":"1995","journal-title":"Sdrizophr: Res"},{"key":"CIT0011","first-page":"159","volume":"4","author":"TANDON R","year":"1997","journal-title":"J. Semtunin Res."},{"key":"CIT0012","first-page":"64","volume":"3","author":"MELTZER HY","year":"1995","journal-title":"Cl\/n. Neuracci"},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/09540269509022974","volume":"7","author":"HESSELINK JMK, SAMBUNARIS A","year":"1995","journal-title":"Int. Rev Psych."},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/BF02245607","volume":"124","author":"HERTEL P","year":"1996","journal-title":"Psychopharmacology"},{"key":"CIT0019","first-page":"774","volume":"288","author":"KUROKI T","year":"1999","journal-title":"j Pharmacol Exp. Ther."},{"key":"CIT0020","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/j.1471-4159.1990.tb01230.x","volume":"54","author":"MOGHADDAM B","year":"1990","journal-title":"Neurochem."},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0893-133X(99)00057-3","volume":"21","author":"SPROUSE JS","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"CIT0024","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00002826-199310000-00002","volume":"16","author":"BRILEY M","year":"1993","journal-title":"Clin. Neuropharmacol"},{"key":"CIT0025","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3928\/0048-5713-19960201-09","volume":"26","author":"SHARMA RE SHAPIRO LE","year":"1996","journal-title":"Psychiatric Ann"},{"key":"CIT0026","first-page":"1","volume":"2","author":"TANDON R","year":"2000","journal-title":"Advances in Preclirilcal and Clinical Psychiatry"},{"key":"CIT0028","first-page":"275","volume":"49","author":"AWEEKAF, JAYESEKARAD,","year":"2000","journal-title":"BE j Clin. Pharmacol"},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1365-2125.2000.00147.x","volume":"49","author":"MICELI JJ","year":"2000","journal-title":"Brj Clin. Pharmacol"},{"key":"CIT0030","first-page":"863","volume":"25","author":"PRAKASH C","year":"1997","journal-title":"Drug Metab. Dispos."},{"key":"CIT0031","first-page":"21","volume":"49","author":"EVERSON G","year":"2000","journal-title":"ANDERSON KE etal.: The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function. Brj Clin. Pharmacol"},{"key":"CIT0033","first-page":"15","volume":"49","author":"WILNER KD","year":"2000","journal-title":"BARIS B etal.: Single- and multiple-dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers. Br j. Clin. Pharmacol"},{"key":"CIT0034","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1365-2125.2000.00153.x","volume":"49","author":"MUIRHEAD GJ","year":"2000","journal-title":"Br j. Clin. Pharmacol"},{"key":"CIT0036","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2125.2000.00156.x","volume":"49","author":"LAURENT A","year":"2000","journal-title":"BE j. Clin. Pharmacol"},{"key":"CIT0037","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1365-2125.2000.00157.x","volume":"49","author":"LAURENT A","year":"2000","journal-title":"BE j Clin. Pharmacol"},{"key":"CIT0038","first-page":"61","volume":"49","author":"APSELOFF G","year":"2000","journal-title":"ANZIANO RJ etal.: The effects of ziprasidone on steady-state lithium levels and renal clearance of lithium. Br. J. Clin. Pharmcol"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199808000-00009"},{"key":"CIT0043","first-page":"27","volume":"21","author":"KECK PE Jr","year":"2001","journal-title":"Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two double-blind, placebo-controlled, multicenter studies. j. Clin. Psychopharmacol"},{"key":"CIT0048","volume":"13","author":"MELTZER HY O'CONNOR","year":"2000","journal-title":"In: Abstracts of the Annual Meeting of the American College of Neuropsychopharmacology San Juan, PR (December"},{"key":"CIT0049","volume":"13","author":"ROMANO SJ","year":"2000","journal-title":"In: Abstracts of the Annual Meeting of the American College of Neuropsychopharmacology San Juan, PR (December"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.2.6.1033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T15:49:32Z","timestamp":1625932172000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.2.6.1033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":31,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2005,2,24]]},"published-print":{"date-parts":[[2001,6]]}},"alternative-id":["10.1517\/14656566.2.6.1033"],"URL":"https:\/\/doi.org\/10.1517\/14656566.2.6.1033","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}